Most people are first considered for a statin between the ages of 40 and 75, but the decision depends on more than age alone. Current guidelines from the American College of Cardiology and American Heart Association identify three primary groups who benefit from statin therapy for prevention, plus anyone who has already had a heart attack or stroke. Where you fall among these groups determines not just whether to start, but how aggressively.
The Three Main Groups for Primary Prevention
If you haven’t had a cardiovascular event, guidelines point to three situations where starting a statin is recommended:
- LDL cholesterol at or above 190 mg/dL. This triggers a recommendation for high-intensity statin therapy regardless of age (starting at 20) and without needing a formal risk calculation. LDL at this level carries enough long-term danger on its own that treatment is considered essential.
- Diabetes between ages 40 and 75. People with diabetes face a significantly higher risk of heart disease. A moderate-intensity statin is generally recommended for this group. For those under 40 with diabetes, statins may still be considered if LDL stays above 100 mg/dL or additional risk factors are present, like high blood pressure or smoking.
- Sufficient 10-year cardiovascular risk. For everyone else aged 40 to 75, the decision hinges on a risk calculation and a conversation with your clinician. A 10-year risk of 7.5% or higher typically opens the door to statin therapy. The U.S. Preventive Services Task Force sets its threshold slightly higher, recommending statins when 10-year risk reaches 10% or more and at least one additional risk factor is present (diabetes, high cholesterol, high blood pressure, or smoking).
How Your 10-Year Risk Is Calculated
The standard tool is the Pooled Cohort Equations calculator, which estimates your chance of having a heart attack or stroke over the next decade. It uses your age, sex, race, total cholesterol, HDL cholesterol, blood pressure, whether you take blood pressure medication, whether you have diabetes, and whether you smoke. Your doctor can run this in under a minute.
A result below 5% is considered low risk, 5% to 7.4% is borderline, 7.5% to 19.9% is intermediate, and 20% or above is high. At intermediate risk, the guidelines specifically recommend a detailed conversation between you and your clinician before starting a statin, because additional factors can push the decision one way or the other.
Risk-Enhancing Factors That Tip the Scale
When your calculated risk lands in the borderline or intermediate zone, certain additional factors can strengthen the case for starting a statin. Having three or more of these factors is enough to identify patients who would likely benefit, even if their numbers alone don’t look alarming. These include:
- Family history of premature heart disease (a parent or sibling who had a heart attack or stroke before age 55 for men, 65 for women)
- Chronic kidney disease
- Metabolic syndrome (a cluster of high blood sugar, excess abdominal fat, abnormal cholesterol, and high blood pressure)
- Inflammatory conditions like rheumatoid arthritis, psoriasis, lupus, or HIV
- South Asian ancestry, which carries a higher baseline cardiovascular risk
- Pregnancy-related complications such as preeclampsia or premature menopause (before age 40)
- Persistently elevated LDL at 160 mg/dL or above, even if it hasn’t reached the 190 threshold
- Elevated inflammatory markers, specifically a high-sensitivity C-reactive protein level of 2 mg/L or higher
None of these factors alone automatically means you need a statin, but stacking several of them meaningfully changes the risk picture.
When a Calcium Score Scan Helps
If you’re on the fence, a coronary artery calcium (CAC) scan can provide a tiebreaker. This is a low-dose CT scan that detects calcified plaque in your heart’s arteries and produces a score. A score of zero is reassuring. For many people, particularly those at borderline or intermediate risk, a zero score supports deferring statin therapy and focusing on lifestyle changes instead.
A score above 100, or above 300, shifts the conversation strongly toward starting treatment. For adults aged 76 to 80 with LDL between 70 and 189 mg/dL, a CAC of zero is specifically cited as a reason to hold off on statins. Even younger adults under 40 who have concerning risk factors can use a CAC scan: any score above zero favors more aggressive prevention.
After a Heart Attack or Stroke
If you’ve already had a cardiovascular event, the question isn’t whether to start a statin but how high the dose should be. High-intensity statin therapy is the standard of care after a heart attack, and the evidence for starting at the highest tolerated dose early is strong. A large study of post-heart attack patients found that those started on high-dose statins had a 13% lower rate of death compared to moderate-dose patients and a 19% lower rate compared to low-dose patients. Recurrent heart attacks and strokes were also significantly less common in the high-dose group.
Despite this, real-world prescribing often falls short. In the same study, only about one in four patients received a high dose after their heart attack, while roughly 70% received a moderate dose. If you’ve had an event and aren’t sure about your dosage, it’s worth asking whether a higher intensity would be appropriate for you.
Statins After Age 75
Guidelines get more cautious here, but they don’t draw a hard stop at 75. The 2018 ACC/AHA guidelines state it’s reasonable to consider starting a moderate-intensity statin for adults over 75 with LDL between 70 and 189 mg/dL. The available evidence, while not as robust as for younger adults, generally points toward benefit in this age group.
The decision becomes more individual. Clinicians are encouraged to weigh factors specific to aging: functional status (both physical and cognitive), the number of other medications being taken, frailty, life expectancy, and personal preference. Someone who is 78, active, and otherwise healthy may benefit significantly from a statin. Someone who is 82 with multiple serious conditions and limited life expectancy may not gain enough benefit to justify adding another medication. For people already taking a statin who turn 75, continuing therapy is generally considered reasonable rather than automatically stopping it.
What About People Under 40?
For most adults under 40, statins aren’t part of the conversation unless LDL is at or above 190 mg/dL, which often signals a genetic cholesterol condition called familial hypercholesterolemia. In that case, guidelines recommend high-intensity therapy starting at age 20. Younger adults with diabetes and additional risk factors may also be candidates, though the evidence base is thinner for this age group. A coronary calcium scan can help younger people with strong family histories or multiple risk factors understand whether early treatment makes sense.